Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia
Cachexia is an important cause of secondary morbidity and mortality in patients with cancer. Previous studies have suggested that cancer-associated cachexia may be due in part to tumor-specific production and secretion of a glycosylated peptide, proteolysis-inducing factor, originally identified in...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2004-09, Vol.10 (17), p.5862-5869 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cachexia is an important cause of secondary morbidity and mortality in patients with cancer. Previous studies have suggested
that cancer-associated cachexia may be due in part to tumor-specific production and secretion of a glycosylated peptide, proteolysis-inducing
factor, originally identified in a murine cancer cachexia model. We report here the cloning of a human cDNA that generates
a peptide having high-sequence homology to this proteolysis-inducing factor. Constitutive expression of human proteolysis-inducing
factor is low or absent in most normal human tissues but appears to be elevated in some human tumors. Stable forced expression
of human proteolysis-inducing factor in multiple murine and human cell lines results in a secreted protein, but no glycosylation
of the protein is detected. In addition, tumor xenografts engineered to overexpress human proteolysis-inducing factor protein
do not induce cachexia in vivo . These findings raise important questions as to potential cross-species differences in protein sequence and processing of
murine proteolysis-inducing factor and human proteolysis-inducing factor, as well as the nature of the relationship between
human proteolysis-inducing factor and the development of cancer cachexia. |
---|---|
ISSN: | 1078-0432 1557-3265 |
DOI: | 10.1158/1078-0432.CCR-04-0435 |